UMB Bank’s Quest Diagnostics DGX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$7.05M Buy
33,268
+11,494
+53% +$2.26M 0.09% 152
2026
Q1
$4.27M Sell
21,774
-431
-2% -$83.7K 0.06% 188
2025
Q4
$3.85M Sell
22,205
-1,028
-4% -$187K 0.05% 205
2025
Q3
$4.43M Sell
23,233
-937
-4% -$166K 0.07% 173
2025
Q2
$4.34M Sell
24,170
-627
-3% -$109K 0.07% 173
2025
Q1
$4.2M Buy
24,797
+774
+3% +$127K 0.07% 169
2024
Q4
$3.62M Buy
24,023
+22,544
+1,524% +$3.51M 0.06% 186
2024
Q3
$230K Buy
1,479
+625
+73% +$93.3K ﹤0.01% 545
2024
Q2
$117K Buy
854
+147
+21% +$20.1K ﹤0.01% 655
2024
Q1
$94.1K Sell
707
-723
-51% -$93.8K ﹤0.01% 713
2023
Q4
$197K Sell
1,430
-30
-2% -$3.94K ﹤0.01% 583
2023
Q3
$178K Hold
1,460
﹤0.01% 587
2023
Q2
$205K Sell
1,460
-447
-23% -$61.6K ﹤0.01% 575
2023
Q1
$270K Sell
1,907
-5
-0.3% -$715 ﹤0.01% 507
2022
Q4
$299K Sell
1,912
-133
-7% -$19.1K ﹤0.01% 495
2022
Q3
$251K Sell
2,045
-193
-9% -$25.4K ﹤0.01% 552
2022
Q2
$297K Buy
2,238
+226
+11% +$30.8K ﹤0.01% 546
2022
Q1
$275K Sell
2,012
-236
-10% -$32.9K ﹤0.01% 590
2021
Q4
$389K Buy
2,248
+499
+29% +$75.9K ﹤0.01% 526
2021
Q3
$254K Hold
1,749
0.01% 336
2021
Q2
$231K Hold
1,749
0.01% 345
2021
Q1
$224K Hold
1,749
0.01% 337
2020
Q4
$208K Buy
+1,749
New +$213K 0.01% 337

Other funds holding DGX

UMB Bank's DGX Position: Q2 2026 in Review

UMB Bank increased its Quest Diagnostics (DGX) stake by 53% in Q2 2026, buying an estimated $2.26M and bringing the position to 33,268 shares worth $7.05M. The position accounts for 0.09% of the portfolio, ranked #152.

UMB Bank first reported a position in DGX in Q4 2020 and has held it in 23 quarters since. 1,100 funds tracked by Wall St. Rank hold DGX as of Q2 2026.

  • UMB Bank held 33,268 shares of Quest Diagnostics worth $7.05M as of Q2 2026.
  • UMB Bank bought 11,494 Quest Diagnostics shares in Q2 2026, an estimated $2.26M.
  • Quest Diagnostics made up 0.09% of UMB Bank's portfolio in Q2 2026, its #152 holding.
  • UMB Bank first reported a position in Quest Diagnostics in Q4 2020 and has held it in 23 quarters since.
  • 1,100 funds tracked by Wall St. Rank held Quest Diagnostics as of Q2 2026.

Based on UMB Bank's 13F filing for Q2 2026, filed 13 Aug 2026.